Mediso Medical Imaging Ltd.
Clinical and pre-clinical solutions for hospitals, clinics and scientific institutions
Mediso is a leading supplier of molecular imaging techniques to the health care and medical research institutions of the world.
Mediso has a complete profile of system development, manufacturing, selling and servicing of multi-modality imaging devices. With over 30-year expertise and 1,400+ clinical systems installed Mediso offers complete solutions from imaging devices to evaluation and quantification software for both clinical patient care and scientific research.
Besides a unique triple modality clinical SPECT/CT/PET system, the new AnyScan® TRIO family utilizing a triple head SPECT detector design and dedicated multi-pinhole collimation technology to achieve unparalleled sensitivity and quantitation accuracy especially for neuro- and cardiac imaging. The wide energy-range detectors of the AnyScan® TRIO TheraMax offers the best sensitivity and spatial resolution for targeted alpha- and beta radionuclide therapy.
Mediso has a leader position in the preclinical nuclear imaging market with over 320 commissioned systems around the world. Beyond the market leading nanoScan® PET/CT and SPECT/CT, Mediso also offers standalone MRI and integrated PET/MRI systems based on a cryogen-free magnet with 3T or 7T field strength and a PET insert for simultaneous PET/MRI imaging.
Brands: NanoScan, AnyScan, Nucline, InterView, InterView Fusion, Tera-Tomo